How can cytology be most effectively applied for cervical cancer case-finding in a population of women? Since the highest incidence occurs among women in their 20s, to incorporate cytology as a routine part of pre-and post-natal care provides a built-in opportunity to reach the great bulk of young women during their years of greatest risk. This might inculcate the habit of periodical examination. The increasing use of oral contraceptives brings women into the hands of physicians during the child-bearing years and offers another opportunity for screening women cytologically during their years of greatest risk. Until we are more certain of the effect of these hormone preparations on the cervical epithelium such examinations initially and periodically are essential. Women seen for menopausal symptoms also provide an opportunity for cytological examination and this age period seems the most likely time for an old in-situ lesion to become a new invasive cervical cancer. For older women the opportunities for screening and the expected results are less certain.
How can cytology be most effectively applied for cervical cancer case-finding in a population of women? Since the highest incidence occurs among women in their 20s, to incorporate cytology as a routine part of pre-and post-natal care provides a built-in opportunity to reach the great bulk of young women during their years of greatest risk. This might inculcate the habit of periodical examination. The increasing use of oral contraceptives brings women into the hands of physicians during the child-bearing years and offers another opportunity for screening women cytologically during their years of greatest risk. Until we are more certain of the effect of these hormone preparations on the cervical epithelium such examinations initially and periodically are essential. Women seen for menopausal symptoms also provide an opportunity for cytological examination and this age period seems the most likely time for an old in-situ lesion to become a new invasive cervical cancer. For older women the opportunities for screening and the expected results are less certain.
How big a proportion of newly developing disease has a short in-situ phase and how frequently cytology needs to be repeated to find these while they are still occult is a question for which we do not have an answer. Does new disease develop in women over 60? Fidler & Boyes (unpublished data) had not found a case of carcinoma-in-situ developing in this age period among women cytologically negative on previous examinations in British Columbia until recently and they believe new disease is unusual in this age period. In Memphis incident cases of carcinoma-in-situ were not found among Negro women 60 years and older in the period through 1961, but a few cases were found among white women.
We still have questions to be answered in the application of this our most effective cancer case-finding method. I hope that workers in England, without many of the barriers and ihandicaps offered by our system of providing -medical care to this kind of study, will fill in some of the important details that are lacking in our knowledge of the pathogenesis of cervical cancer. The Presymptomatic Diagnosis of Breast Cancer by J L Hayward MB FRCS (Imperial Cancer Research Fund, and Department ofSurgery, Guy's Hospital, London) Breast cancer in women accounts for approximately 1 in 4 of cancer deaths and for about 3 in every 100 deaths from all causes. In spite of refinements in the treatment of the early disease and new methods of palliation, giving prolonged periods of remission in the advanced stages, there is no evidence that the death rate is decreasing. Better results could be obtained by developing new and improved methods of treatment or possibly by initiating treatment at an earlier stage. Provided there is a simple progression in the spread of breast cancer from localization in the breast to the involvement of the axillary lymph nodes to the development of distant metastases, the earlier treatment is established in this progression the more likely would be a permanent cure. Indeed the most favourable circumstance would be for the patient to be treated whilst still symptom free. Diagnosis at this stage has been achieved satisfactorily for cancer of the cervix by using cervical smears, and if similar methods were available for the early diagnosis of breast cancer a major improvement in the results of treatment might be expected.
To be feasible, there would have to be a method of diagnosis, without frequent recourse to biopsy, which could detect lesions with minimal signs in the breast. If large numbers were to be studied it would be unlikely that examinations could be carried out often enough to be practical, and therefore a method is also needed for detecting a small high-risk group on which a programme of frequent and intense study would be workable. There is now evidence that sufficiently accurate diagnostic methods are becoming available and also that a simple test may be elaborated within the next few years to isolate a group of women who stand a greater than normal risk of developing breast cancer.
Clinical Methods
Self examination by the patient: In the United States an extensive campaign has been carried out during the past two decades to persuade women both to examine themselves at regular intervals and to report to their doctor at the first sign of any abnormality. It is not known to what extent this is done nor is it known how many women develop a cancer phobia as a consequence, but it seems likely that it has resulted in a better understanding by the public of the problems involved. If it is having an effect one would expect a bigger proportion of women to report with the growth confined to the breast and with no axillary metastases. Figures over the last twenty years seem to support this, although the change has been slight. In the five years from 1945 to 1949, 38 % of the patients reporting had localized disease, wkereas in the five years from 1955 to 1959, 42% had localized disease (Cutler 1966) .
Routine examination: Another method of establishing an early diagnosis is to encourage women to have their breasts examined routinely at a cancer detection clinic. There are several such clinics in the United States and reports are now coming in of their value. Recently Gilbertsen (1966) described the results at the Cancer Detection Centre in the University of Minnesota Medical Center, Minneapolis, where 6,614 women have undergone 29,722 annual examinations over a period of seventeen years. In these women 43 cases of breast cancer have been detected, which is approximately 1 in every 690 examinations. None of these tumours had been noticed by the patient and 75% of them were found to be localized to the breast at subsequent operation. Following radical surgery 96 % of those with localized disease and 75% of those with axillary metastases have survived five years; these results, although based on small numbers, are much better than would be expected when treating patients in an ordinary clinic. Although these figures could be interpreted as resulting from observing the patients earlier in the 'natural history of their disease, preliminary data on the ten-year survival rate indicate that the improved survival is maintained.
Radiological Methods
Mammography: It has now been shown conclusively that most cancers of the breast can be demonstrated radiologically by soft-tissue X-ray. Not only can a palpable carcinoma be distinguished from a benign lesion but also there is evidence that cancer can be detected in breasts which are clinically normal (Fig 1) . Mammography has been used in several surveys of normal women to assess its value in the detection of presymptomatic nonpalpable breast cancer. About 10,000 women of the cancer-bearing age have had mammograms on at least one occasion (Stevens & Weigen 1966) . In these 10,000 women, 31 cancers have been detected, of which 4 already had axillary metastases. These patienfs were subsequently treated by conventional radical surgery but it is too early to assess survival. It would be surprising, however, as the disease was localized in over 80% and the average size of the tumour was less than 1 cm in diameter, if the survival rate was not higher than that normally experienced. Other information which has been obtained from these trials indicates that the method could be of practical use on a larger scale: (1) The false negative rate was not high and amounted to only about 10-15% of the total biopsies. (2) Over 80% of the patients agreed to biopsy when it was recommended. (3) The rate of 3 1 cancer cases from 1,000 examinations approximates to the rate obtained for cervical smears although of course the curability and specificity would be much higher from the latter.
In 1963 a trial was set up by the Health Insurance Plan of Greater New York (Shapiro et al. 1966) to test the value of combined mammography and clinical examination as a screening procedure for breast cancer. Study and control groups were selected by random sample and the women in the study group were examined both radiologically and clinically on three occasions at yearly intervals whilst those in the control group were not specially encouraged to be examined. So far nearly twice as many breast cancers have been found in the study group compared with the control group and a higher percentage of these have negative nodes. The technique has certain disadvantages, such as the need for repeated X-ray examinations, but holds the promise of being a useful and accurate tool for clinical screening.
Xeroradiography: This is a relatively new method of X-raying soft tissue lesions and results in a picture with much better definition than obtained from mammography. It depends on using a charged metal plate coated with selenium; X-rays cause a loss of charge from this plate and when it is subsequently dusted with calcium carbonate it provides an image similar to that of the standard X-ray. The whole process is dry so no dark room is needed and the resolving power is much greater than with the usual techniques (Fig 2) . Xeroradiography can distinguish a mesh with 1,200 lines to the inch whereas a standard X-ray film loses definition with a mesh of 180 lines to the inch. The technique seems to hold great promise but there is not yet sufficient information on its use in cancer of the breast (Ruzicka et al. 1965) .
Thermography: This depends on the fact that cancer in the breast is hotter than both the surrounding breast tissue and benign lesions. The heat seems to be due both to an increased rate of metabolism and to an increased blood supply (Lawson & Gaston 1964) . The technique consists of scanning the breast with an infra-red camera and transducing the heat energy to a light pattern which can be recorded by a polaroid camera. The hotter the area, the whiter it appears on the ensuing photograph (Fig 3) . It has the advantage that no X-rays are used and therefore there is no potential hazard to the patient and examinations can be carried out as often as desired. Its disadvantages are that the present techniques are rather time consuming, entailing equilibration of the patient to the surrounding room temperature and it may well be that very small lesions would not be detected (Connell et al. 1966 ).
The High-risk Group For any of these techniques to be practical an attempt must be made to isolate a group of women who stand an abnormally high risk of developing breast cancer. It has been well known for many years that there are marginal differences in the incidence of breast cancer in different types of women, and certain clinical groups with a greater risk of developing the disease could be defined. For instance, families are encountered in which several members have suffered from breast cancer and it is known to occur more frequently in women whose mothers or sisters have had the disease (Lilienfeld 1963) . Single women are more prone than married women (Wynder et al. 1960) , and in married women the incidence is inversely proportional to the number of children born (Pedler 1940) . Lactation may be protective and the earlier in life the menopause occurseither spontaneously or surgically inducedthe less is the chance of developing cancer of the breast (Lilienfeld 1963) . Similarly there is a positive association of breast cancer with carcinoma of the body of the uterus (Bailar 1963) and it is postulated that patients who have had cystic disease of the breast are about twice or three times more likely to develop subsequent cancer (Davis et al. 1964 ).
However, when all these factors are taken into account, none of the differences is very great and it does not seem that this is a practical method of isolating a high risk group. Recent work has indicated another and more promising field of study. It has been reported that many patients with early breast cancer excrete abnormal amounts of certain steroids in their urine (Bulbrook et al. 1962) . In particular, the levels of ttiocholanolonean androgen metaboliteare lower than normal and the levels of the 17hydroxycorticosteroids are higher than normal. It was later reported (Bulbrook et al. 1964 ) that the patients who show this abnormalityabout half those submitted to radical mastectomyhave a high subsequent recurrence and death rate. The measurements were carried out on the urine of patients who had been admitted to hospital with the first symptoms of breast cancer and who had had a radical mastectomy as a curative procedure. It seemed probable either that the abnormalities had arisen with the development of the cancer and were a metabolic response to the presence of the tumour, or that they had been present before the disease had developed. In the latter event they might be detectable in those women in the general population who were likely to develop breast cancer subsequently. To test this hypothesis it was necessary to measure the excretion of these steroids in a larger number of normal women.
Each year about one woman in a thousand would be expected to develop breast cancer, and her steroid excretion would already have been estimated. It would be known whether it had been abnormal before she had contracted the disease.
A study of this nature was begun five years ago on the Island of Guernsey, where 5,000 women between the ages of 35 and 55 were asked to provide a twenty-four-hour specimen of urine and to allow their doctor to supply information should they subsequently develop breast cancer. After collection, the urine specimens were frozen and flown to London; here they were extracted and the extracts stored at -200C. When a cancer case was reported, the analysis on the urine extract was completed and compared with controls taken from other women in the study who had been matched as nearly as possible by age, weight, parity, &c. It could thus be seen if the steroid excretion of the women who developed cancer was different from that of the normal controls. This experiment has now been running for five years; nearly 4,500 urines have been collected and approximately 15 cases of cancer of the breast have so far occurred. It is too early yet to draw any conclusions from the results but, if it should prove that a proportion of women who subsequently develop breast cancer have an abnormal steroid excretion, then the isolation of a high-risk group becomes a feasible proposition. The estimations are time consuming, laborious and require a highly skilled laboratory staff, but if they are to be used on a much larger scale, quicker and simpler methods could probably be developed.
More recently another study, in Adelaide, has been made on the sex chromatin status of the buccal epithelium of women with breast cancer (Stanley et al. 1966 ). This has shown that these women have certain sex chromatin anomalies which are not present in normal women or in patients with other malignant tumours. The authors suggest that these patients might represent a susceptible fraction of the population and it is to be hoped that attempts will be made in the near future to test a large number of the normal population in a similar trial to that being undertaken in Guernsey.
Thus by means of steroid measurement or possibly sex chromatin counts it may be possible to isolate a proportion of the population which would stand a risk of perhaps 1 in 5 of developing breast cancer and then the more specific diagnostic tests could play a major role in detecting the early lesion. Of the methods discussed, routine annual clinical examination with mammography seems to hold most promise. The experience of the New York trial suggests that the equipment, administration and particularly the personnel required for providing such a public service would not be beyond the scope of most countries' medical potential. Possibly a combined clinic, where tests for other malignancies could also be carried out, would be the most practical proposi-tion. All this is still in the future but if current work is successful it could become practice within five or ten years. Presymptomatic detection of breast cancer could take its place with the cervical smear and mass radiography to provide a real advance in the management of the disease.
The Presymptomatic Diagnosis of Lung Cancer by G Z Brett MD (Mass Radiography Service, North West Metropolitan Region London) One of the results of using mass radiography for large-scale screening of apparently healthy persons has been the discovery of unsuspected lung cancer in examinees without chest symptoms or none compelling medical consultation. It is in this wider sense that routine mass radiography has made it possible to arrive at a presymptomatic diagnosis of the disease.
In an earlier investigation carried out by the North West Metropolitan Mass Radiography Service it was found that the percentage of both resection and five-year survival after resection was, by chance, the same, 55 % in lung cancer detected by routine mass radiography and 32% in patients referred for chest radiography by general practitioners (Brett 1959) . The value of these results was, however, reduced by the fact that the rate of detection of the 'presymptomatic' cases was only 0-27 per thousand men of all ages, compared with a high yield of 26-7 per thousand in doctors' patients.
It seemed reasonable to assume that the low rate of detection of lung cancer by routine mass radiography was related to the conventional three-yearly or longer intervals between repetitive surveys of the population at risk and that to increase this rate routine surveys would have to be carried out at more frequent intervals and be directed towards men in the cancer age. In order to assess the feasibility and value of such surveys a study was needed which would be so designed as to give a valid answer to the following questions: (1) Were frequent (e.g. six-monthly) routine surveys practicable? (2) Would the detection of presymptomatic lung cancer be increased by such surveys? (3) Would six-monthly surveys affect the rate of resection? (4) Would lung cancer mortality be reduced in a population sample which was offered six-monthly examinations compared with one that was not ?
The answer to most of these questions could have been obtained by investigating the lung cancer experience of one group of men subjected to frequent X-ray examinations. Since, however, it was also intended to assess the effect of this method on lung cancer mortality it was necessary to introduce into the study two population samples of which one, a test group, would be offered six-monthly X-ray examinations over a period of three years, while the other, a control group, would be X-rayed only at the beginning and the end of that period. The mortality from lung cancer in the two groups could then be compared. Both groups would be confined to men aged 40 and over. As an investigation on these somewhat complicated lines had not been attempted before, the planning and method of the scheme were empirical.
Method ofInvestigation
The basic requirement was to secure a sufficient number of male volunteers for the two groups in the scheme. Experience indicated that an approach to industry would provide from many aspects a more manageable scheme than dealing with individuals. During the two years preceding the actual X-raying of volunteers the number of men over 40 employed in industrial establishments of a suitable size was ascertained. The support of management and unions of the eligible firms for the aims of the research project was secured and their co-operation was of a high order. The firms, mainly factories, comprising about 75,000 potential volunteers, were sorted into two groups by a statistician. They were broadly cross-matched into type of work and area and the groups were finally divided into test and control by random sampling numbers. The test group consisted of 75 factories and the
